Nuvaira

Maple Grove, MN · Founded 2008 · Privately Held (backing)

Developer of a medical device designed to improve outcomes for patients suffering from obstructive lung diseases. Nuvaira is based in Maple Grove, MN and was founded in 2008. Its last reported valuation was $139 million in Nov 2023. It has raised $244 million across 6 recorded rounds; the latest was a $35.8 million early-stage round in Feb 2026.

Last reported valuation
$139.3M
Oct 2026
Priced at
—
Total raised
$244.0M
Last round
Early Stage VC
Feb 2026

Nuvaira key facts

as of Oct 2026
  • Developer of a medical device designed to improve outcomes for patients suffering from obstructive lung diseases.
  • Nuvaira is valued at approximately $139.3M as of Oct 2026 (last reported valuation).
  • It has raised $244.0M across 6 recorded rounds; the latest was Early Stage VC ($35.8M) in Feb 2026.
  • Notable investors include Qiming Venture Partners USA, Vertex Growth, Lightstone Ventures, Versant Ventures, Richard King Mellon Foundation — 14 tracked in total.
  • Nuvaira has filed 8 Form Ds with the SEC since 2018, most recently Aug 2025 ($979K sold to 8 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$139.3M

Nuvaira's last reported valuation, Nov 2023. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Nuvaira with a free account
  • ·The complete investor list: 14 names
  • ·Watch Nuvaira: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Nuvaira funding rounds

6 rounds
Feb 2026Early Stage VC$35.8MSEC filing▮
Aug 2025Seed Round$979KSEC filing▮
Nov 2023Early Stage VC$15.1MSEC filing▮
Jul 2020Early Stage VC$31.3MSEC filing▮
Feb 2019Early Stage VC$25.0MSEC filing▮

Nuvaira valuation

Nuvaira's last reported valuation was $139 million in Nov 2023. No priced round, secondary trade or fund mark has surfaced since.

How much has Nuvaira raised?

Nuvaira has raised $244 million in total; 6 of its rounds are on record, from 2018 on. The largest on record was a $979,184 seed round in Aug 2025; the most recent was a $35.8 million early-stage round in Feb 2026.

Nuvaira has filed 8 Form Ds with the SEC since 2018, most recently in Aug 2025 ($979,184 sold to 8 investors).

Nuvaira investors

14 investors are on record for Nuvaira, including Qiming Venture Partners USA, Vertex Growth, Lightstone Ventures and Versant Ventures. The early-stage round in Feb 2026 drew 9 investors.

About Nuvaira

Developer of a medical device designed to improve outcomes for patients suffering from obstructive lung diseases. The company's device is a novel, catheter-based system to treat overactive airway nerves, a common disease feature of both COPD and asthma, enabling physicians to reduce the clinical consequences of neural hyperactivity.

Sector
Healthcare
HQ
Maple Grove, MN, United States
Founded
2008
Employees
35
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.